Form 4: Lilly Endowment Inc. Sells Shares of Eli Lilly & Co.

Lilly Endowment Inc. sold 17,229 shares of Eli Lilly & Co. common stock in multiple transactions on June 24, 2024.

Summary

• Lilly Endowment Inc. sold 16,029 shares of Eli Lilly & Co. common stock at a weighted average price of $902.30 per share on June 24, 2024.
• These shares were sold in multiple transactions with prices ranging from $902.00 to $902.88.
• Additionally, Lilly Endowment Inc. sold 1,200 shares of Eli Lilly & Co. common stock at a weighted average price of $903.418 per share on the same day.
• These shares were sold in multiple transactions with prices ranging from $903.23 to $903.55.
• Following these transactions, Lilly Endowment Inc. beneficially owns 97,556,910 shares of Eli Lilly & Co. common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing a stock sale by a major shareholder. It doesn't indicate any positive or negative sentiment, it is a neutral transaction.

Industry Context

This is a routine filing related to a significant shareholder's transactions in the company's stock. Such filings are common and provide transparency into insider trading activity.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders in publicly traded companies.
• The transaction details provided are consistent with the requirements of the Securities and Exchange Commission (SEC).
• The level of detail, including weighted average prices and price ranges, is typical for these types of filings.

Stakeholder Impact

• The sale of shares by a major shareholder could have a minor impact on the stock price, but it is unlikely to be significant given the size of the transaction relative to the total shares outstanding.

Key Dates

Keywords

Eli Lilly & Co, Lilly Endowment Inc, stock sale, share transaction, beneficial ownership, common stock